Artivion (AORT) Cash from Investing Activities (2010 - 2026)

Artivion (AORT) reported Cash from Investing Activities of -$10.5 million for Q1 2026, down 188.7% on a YoY basis from $11.8 million in Q1 2025, and up 65.57% quarter-over-quarter from -$30.5 million in Q4 2025.

Artivion (AORT) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Artivion has reported Cash from Investing Activities for 17 years, with the latest figure at -$10.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities fell 188.7% year-over-year to -$10.5 million; the trailing twelve-month figure through Mar 2026 stood at -$48.9 million (down 73.33% YoY), and the FY2025 full-year result was -$42.0 million, down 49.15% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$10.5 million, up from -$30.5 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $7.1 million in Q2 2023, with the low at -$30.5 million in Q4 2025.
  • Historically, Cash from Investing Activities has averaged -$5.4 million across 5 years, with a median of -$3.1 million in 2022.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 409.62% — and 2024, when it sank 414.46%.
  • Artivion's Cash from Investing Activities stood at -$2.7 million in 2022, then retreated by 0.04% to -$2.7 million in 2023, then sank by 328.06% to -$11.4 million in 2024, then plunged by 167.02% to -$30.5 million in 2025, then soared by 65.57% to -$10.5 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$10.5 million (Q1 2026), -$30.5 million (Q4 2025), and -$4.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -20.32 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -185.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -816.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -92.80 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -475.32 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -298.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -2.50 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -217.20 Mn
10 Artivion 1.02 Bn 961.48 Mn 75.45 Mn -10.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -10.50 Mn
Mar 31, 2026 -10.50 Mn
Dec 31, 2025 -30.51 Mn
Dec 31, 2025 -30.51 Mn
Sep 30, 2025 -4.61 Mn
Sep 30, 2025 -4.61 Mn
Jun 30, 2025 -3.29 Mn
Jun 30, 2025 -3.29 Mn
Mar 31, 2025 -3.64 Mn
Mar 31, 2025 -3.64 Mn
Dec 31, 2024 -11.43 Mn
Dec 31, 2024 -11.43 Mn
Sep 30, 2024 -10.64 Mn
Sep 30, 2024 -10.64 Mn
Jun 30, 2024 -2.51 Mn
Jun 30, 2024 -2.51 Mn
Mar 31, 2024 -3.61 Mn
Mar 31, 2024 -3.61 Mn
Dec 31, 2023 -2.67 Mn
Dec 31, 2023 -2.67 Mn